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ABSTRACT
Introduction Care homes provide nursing and social care 
for older people who can no longer live independently 
at home. In the UK, there is no consistent approach 
to how information about residents’ medical history, 
care needs and preferences are collected and shared. 
This limits opportunities to understand the care home 
population, have a systematic approach to assessment 
and documentation of care, identifiy care home residents 
at risk of deterioration and review care. Countries with 
standardised approaches to residents’ assessment, care 
planning and review (eg, minimum data sets (MDS)) 
use the data to understand the care home population, 
guide resource allocation, monitor services delivery and 
for research. The aim of this realist review is to develop 
a theory- driven understanding of how care home staff 
implement and use MDS to plan and deliver care of 
individual residents.
Methods and analysis A realist review will be conducted 
in three research stages.
Stage 1 will scope the literature and develop candidate 
programme theories of what ensures effective uptake and 
sustained implementation of an MDS.
Stage2 will test and refine these theories through further 
iterative searches of the evidence from the literature 
to establish how effective uptake of an MDS can be 
achieved.
Stage 3 will consult with relevant stakeholders to test 
or refine the programme theory (theories) of how an 
MDS works at the resident level of care for different 
stakeholders and in what circumstances. Data synthesis 
will use realist logic to align data from each eligible 
article with possible context–mechanism–outcome 
configurations or specific elements that answer the 
research questions.
Ethics and dissemination The University of Hertfordshire 
Ethics Committee has approved this study (HSK/SF/
UH/04169). Findings will be disseminated through 
briefings with stakeholders, conference presentations, a 
national consultation on the use of an MDS in UK long- 
term care settings, publications in peer- reviewed journals 
and in print and social media publications accessible to 
residents, relatives and care home staff.
PROSPERO registration number CRD42020171323; 
this review protocol is registered on the International 
Prospective Register of Systematic Reviews.
BACKGROUND
There are nearly 12 million (11 989 322) 
people aged 65 years and above in the UK 
of which an estimated 1.6 million are aged 
85 years and above, and more than 500 000 
(579 776) people are aged 90 years and 
above.1 However, with greater longevity (eg, 
age 85 years and above) comes higher levels 
of dependency, dementia and comorbidity,2 
which in turn intensify the need for social 
care services.3 Approximately 420 000 older 
people in England and Wales live in care 
homes.4 Care home is a generic term that 
refers to facilities where a number of older 
people live together and have staff available 
24 hours to provide personal care (eg, resi-
dential care or assisted living/supportive 
housing facilities), and for those facilities 
Strengths and limitations of this study
 ► The review will identify what needs to be in place 
to support the implementation of an minimum data 
sets (MDS) in long- term care settings where stan-
dardised approaches to resident assessment and 
data collection are not in place.
 ► The review will demonstrate how using an MDS af-
fects the everyday work and care practices of staff 
and its impact on residents’ care.
 ► The synthesis will integrate qualitative and quanti-
tative evidence that offers transferable learning for 
long- term care settings that do not currently use an 
MDS.
 ► There are time constraints that may result in the 
team focusing on or prioritising some aspects of an 
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where a qualified nurse is required on duty 24 hours to 
provide additional nursing care for more dependent resi-
dents (eg, nursing homes or skilled nursing facilities).5 
The care home population represents the oldest and 
most vulnerable group of older people,6 with approxi-
mately 70% of them living with cognitive impairment6 7 
and 76% requiring assistance with mobility.8
In the UK, there is no consistent approach to how infor-
mation about residents’ medical history, care needs and 
preferences is collected and used. The absence of a national 
mandate, lack of links with National Health Services (NHS) 
data and implementation challenges have meant that a 
minimum data set (MDS) and data- driven approaches to 
resident assessment have been limited to single projects.9 
The lack of a link between care home data and the NHS 
data recently became evident when figures reported by the 
Office for National Statistics during the first three weeks 
of COVID-19 underestimated the impact of the pandemic 
among care home residents.10 All care homes, however, 
routinely collect large amounts of data about their resi-
dents. The challenge is to establish systems of assessment 
and recording that are evidence- based, accessible and valu-
able to those using, providing, commissioning and regu-
lating care services. Without a unified record, there may 
be duplication of assessments, communication failures and 
unmet care needs.11 12 Determining consistent ways to assess 
and document care for residents in the care home settings 
is a priority because over the next two decades, the number 
of older people likely to need long- term care will increase.2
Minimum Data Set in this realist review is defined as a 
comprehensive, standardised account of the characteristics 
and needs and ongoing care of residents living in long- term 
care (care home) settings. The review concentrates on how 
MDS is used by care home staff and what supports effective 
uptake for the benefit of individual residents. It also takes 
account of the involvement of residents themselves and 
their family in influencing how an MDS is used.
There are multiple versions of MDS, which are often 
country specific. However, all versions of MDS share a 
common language and are designed to support an inte-
grated system of care that can support cross- sector clin-
ical and managerial decision- making. One example of an 
MDS is the International Resident Assessment Instrument 
(Inter- RAI), which is developed for long- term care facili-
ties.13 The use of an MDS is often mandated and/or linked 
to national reimbursement systems and quality monitoring. 
Research has demonstrated the value of an MDS to commis-
sioners and service providers in enabling identification 
of care needs and residents at risk of ill health.14–18 They 
can provide a comprehensive account of resident charac-
teristics, resource use and care outcomes in key areas (eg, 
activities of daily living, cognitive performance, pain, cost 
of care and infection).19 However, Kontos and colleagues 
argue that a standardised process such as the MDS fails to 
consistently result in individualised care planning, which 
may suggest problems with content of an MDS.20
There is a dearth of information on For long- term care 
settings making the transition to standardised approaches 
to data collection, what needs to be in place to implement 
an MDS and how its use impacts on staff work, time away 
from care, knowledge of the care home residents, working 
with other healthcare professionals and benefits (or not) to 
residents, staff and residents’ families.
Review aim and objectives
Aim
To develop a theory- driven understanding of how care 
homes’ staff can effectively implement and use a Minimum 
Data Set (MDS) to plan and deliver care of individual 
residents.
Objectives
1. Develop a programme theory describing contexts that 
can support the uptake and use of an MDS in care 
homes.
2. Identify in what circumstances the use of an MDS pro-
duces improved outcomes (including resource use) 
for an individual resident, their family and the care 
home staff and their employing organisation.
Study design
We will conduct a realist review that seeks to formulate, test 
and refine the programme theory while assessing whether 
and how the programme succeeds in the local setting,21 
in order to generate important insights into the UK. A 
programme theory is an overarching theory or model 
of how a programme, or an intervention, is expected to 
work22 and it helps to explain (some of) ‘how and why, in 
the ‘real world’, a specific programme ‘works’, for whom, 
to what extent and in which contexts’.23 The unit of anal-
ysis in a realist review is the ideas and assumptions (ie, the 
programme theories) that underlie an intervention and 
explain how it works to achieve the desired outcomes.
A realist review is an interpretive, theory- driven approach 
to evidence synthesis24 25 to develop a programme theory 
of the causal processes and context- specific factors 
that can explain how an intervention or programme is 
expected to work. Realism is a methodological paradigm 
that sits between positivism (the world is real and can be 
observed directly) and constructivism (given that all we 
know has been processed through the human mind, we 
can never be sure exactly what reality is).26 It is flexible to 
changes and embedded in a social reality that influences 
how a programme is implemented and how various actors 
in that reality respond to it.21
Programmes like the MDS will always rely on human 
agency to affect change. A realist approach argues that 
the features or elements of the programme will produce 
a range of potential responses to the programme which 
will impact on the outcomes.21 24 It assumes that there 
is a knowable, independent reality that will shape how 
different participants react to a programme, whether they 
are aware of these influences or not.27 Thus, uptake and 
implementation of an MDS can lead to different outcomes 
for different stakeholders (eg, residents and their rela-


















pen: first published as 10.1136/bm






3Musa MK, et al. BMJ Open 2020;10:e040397. doi:10.1136/bmjopen-2020-040397
Open access
is involved, the resources available and how the MDS is 
used.28 29
Using a realist approach,21 there are four key linked 
concepts for explaining and building a theory of how 
a programme works: (1) contexts (C), which are often 
the ‘backdrop’ of interventions24, (2) mechanisms (M), 
which are not observed directly but account for what it 
is about programmes that make them work,30 31 charac-
terised as ‘a process that bring about or prevents some 
change in a concrete system’32 and (3) outcomes (O) of 
the intervention (planned or unplanned, visible or not) 
or strategies of the intervention.33 It is the context–mecha-
nism–outcome (CMO) configurations (models indicating 
how programmes activate mechanisms for whom and in 
what conditions, to elicit outcomes) that are the building 
blocks of the theory.25 Thus, in care home settings, staff 
understanding of their responsibility for completing an 
MDS could be a context (C), which triggers how staff 
prioritise recording information as part of care work (M) 
to identify residents at risk of deterioration (O).
The review will follow Pawson’s five practical stages of 
conducting realist reviews: clarify the scope of the review, 
search for evidence, appraise primary studies and extract 
data, synthesise the evidence and draw conclusions and 
disseminate the findings.21 Organised in three stages, we 
will first undertake a scoping of the literature to iden-
tify care home- specific work on the uptake of MDS and 
develop relevant theories around staff uptake and imple-
mentation and outcomes specific to the use of an MDS 
in long- term (care home) settings. Stage 2 will test and 
refine the emergent theories that underpin the use of an 
MDS and that leads to both intended and unintended 
outcomes for staff and residents. Stage 3 will synthesise 
the findings to establish how and when the use of an MDS 
achieves different outcomes for residents, families, staff 
and organisations.
Stages of the review process
Stage 1: Defining the scope of the review, identifying existing 
theories and theory development
This review is nested within a larger review (‘A systematic 
review of process and contextual factors that influence 
research implementation in care homes and identification 
of key measures and outcomes in care home research’). 
The literature identified from the larger review will be the 
starting point for the scoping work.
The scoping of the literature will focus on studies that 
report on how an MDS is used in long- term care (care 
home) settings. Outcomes of interest will be established 
by the project team as an iterative process but are likely to 
include evidence of its impact on: accuracy of reporting, 
needs assessment, staff workload, quality of care, resource 
use, staff satisfaction and access to care.
Literature search strategy
Searches for relevant evidence will include databases of 
peer- reviewed literature Medical Literature Analysis and 
Retrieval System Online (MEDLINE), Excerpta Medica 
dataBASE (EMBASE), Cumulative Index of Nursing 
and Allied Health Literatur (CINAHL), Applied Social 
Sciences Citation Index and Abstracts and sources of 
the grey literature (including OpenGrey and websites of 
organisations relevant to care homes and care of older 
people). Studies for inclusion will be limited to English 
language. We will search data from January 2009 to March 
2020. These initial searches will be complemented by:
1. Searching of both lateral and forward citations of in-
cluded papers paying particular attention to seminal 
papers on the uptake and use of an MDS in long- term 
care settings.
2. Contact with experts who have developed and/or use 
an MDS.
The search strategy will be iterative because predeter-
mined linear search strategies are unlikely to generate 
search results that are adequate for purposes of conducting 
knowledge- building and theory- generating reviews.34 
Throughout the proposed review and based on the 
scoping review findings, we will introduce new, targeted 
search terms not defined in the initial searches.34 35 We will 
use search terms such as care homes, skilled nursing facil-
ities and nursing homes (see online supplemental table 
S1). We will then combine these terms with other terms 
such as MDS, inter- RAI, Research Assessment Instrument 
and RAI using Boolean logic (see online supplemental 
table S1). A comprehensive list of search terms and data-
bases used will be provided in subsequent publications on 
completion of the proposed research.
Literature screening process
Search results relevant to MDS will be downloaded into 
Covidence software. Screening and selection of articles 
will take place in two stages (title and abstract, and full 
text).36 Two reviewers (MKM and GA) will independently 
screen titles and abstracts identified by electronic search 
and applied the selection criteria to potentially relevant 
full- text papers.37 The two reviewers (MKM and GA) 
will then independently screen 10 articles and cross- 
check results to discuss emergent ideas and themes and 
establish consensus on the relevance of the documents. 
Disagreement between MKM and GA will be resolved by 
the third reviewer, CG.
Based on earlier work that used an MDS to collect 
data and cross team discussions,38 the initial programme 
theory will focus on how an MDS is used in long- term 
care. This will be the basis for scoping the literature on 
the challenges of changing systems of care, the need for 
a policy or regulator mandate, how it affects patterns of 
working in the care home, staff involvement in data entry 
and changes in residents’ care. At this stage, we will not 
be assuming causality but we will recognise that these are 
likely to influence uptake and use and resident and staff 
outcomes. Studies have used MDS, or similar approaches 
to document resident, staff and organisational outcomes 
but do not address questions of implementation and 
use will be reviewed to identify supplementary evidence 
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commitment and how information was used and by 
whom). The search strategy will include citation searching 
and grey literature and will be iteratively extended and 
refocused as the review progresses.
Formulating initial programme theories
At this stage, we will investigate demi- regularities in 
outcome patterns by developing a series of ‘if–then state-
ments’ from the scoping literature to summarise the 
dominant arguments and supporting evidence of what 
supports the uptake and use of MDS in long- term care 
settings. This will inform the development of hypotheses 
that posit possible contexts (C) that are the backdrop to 
successful (or not) uptake24 of MDS; the mechanisms (M) 
they trigger32 and planned or unplanned outcomes (O) 
arising from the use of MDS.33 Possible CMO configura-
tions will be discussed across the research team and with 
subject experts on MDS and will inform stage 2 of the 
review phase and additional searches.
There are several ways to conceptualise the develop-
ment and uptake of MDS as many have their roots in 
medical approaches to assessment and health systems 
design. It is therefore likely that the review will be 
informed by and aimed to build on theories of imple-
mentation in long- term care,32 39 uptake of technological 
innovation40 41 assessment of older people with complex 
needs,2 4 8 person- centred care42 43 and risk management 
and quality assurance.44
The introduction of an MDS in care homes is sensitive 
to the resource and policy constraints under which the 
care homes operate. Candidate theories will therefore 
consider the role of the regulator and legal frameworks 
that incentivise (or not) data sharing across organisations.
Literature selection, quality appraisal and data extraction criteria
There will be no restriction on the types of study design 
for eligibility.45 Article selection will be based on the 
extent to which research on the uptake and routine 
use of an MDS can contribute to the development of a 
programme theory of implementation of MDS in long- 
term care settings.
Included studies are likely to cover the following:
 ► Studies on the introduction and development of an 
MDS with care home staff.
 ► Studies that focus on the inclusion and engagement 
of care home staff, residents and their representatives 
in sharing resident data with the specific remit of 
improving resident outcomes.
 ► Implementation studies that provide evidence on 
what facilitates and inhibits the shared documenta-
tion and care planning in care home setting including 
digital innovation.
 ► Studies on commissioning services for care homes 
based on care home- generated data.
No geographical restrictions will apply, although we will 
only include studies that are published in English and 
focus on the uptake and use of an MDS in long- term care 
settings.
Quality appraisal of included articles
The quality of included papers will be carried out in 
accordance with previous appraisal work within a realist 
project.29 36 The quality appraisal of included studies will 
be combined with data extraction, a technique usually 
employed in realist review.46 Realist reviews employ various 
techniques to assess the quality of evidence by drawing on 
evidence from a wider range of sources unlike traditional 
systematic reviews that only focus on the methodological 
quality of studies.29 36 As quality of evidence is not limited 
to the methodological quality, or hierarchy of evidence in 
realist reviews,29 each article in this review will be assessed 
based on its trustworthiness and applicability to the 
research questions. Consistent with the realist approach, 
we will use an iterative approach to determine whether an 
article is considered ‘good enough and relevant’ to answer 
our research questions.47 Good enough will be based on 
the reviewers’ own assessment of the quality of evidence, 
for example, if it is considered to be of a sufficient stan-
dard for the research question, and relevance will relate 
to whether the authors provided sufficient descriptive 
detail and/or theoretical discussion to contribute to the 
initial programme theories development.37
The quality appraisal in this review will be assessed on 
a case by case basis considering the opportunities for 
learning, scientific rigour of evidence and relevance to 
the review questions.46 Two reviewers (MKM and GA), 
in consultation with CG, will lead this process. Weaker 
papers and those with equivocal or negative findings will 
be considered if they contribute to the overall programme 
theories.
Data extraction
Data extraction will be conducted on the basis of rele-
vance to the review questions and will be based on realist 
guidelines to address questions that explore ‘what is it 
that supports (or hinders) an MDS implementation in 
care homes, and how care home staff use and interpret 
an MDS to guide residents’ care?’36 From the extracted 
data, two reviewers (MM and GA) will independently rate 
the studies as either yes, no or maybe in terms of whether 
the particular article meets inclusion criteria. We will use 
‘maybe’ for issues that cannot be answered based on the 
information available in the publication. Then the two 
reviewers (MM and GA) will meet with a third reviewer 
(CG) who will serve as an advisor to verify, confirm or 
reject inclusion of the data. From relevant articles, several 
‘if–then’ statements will be made from which initial 
programme theories will be made.
Data synthesis
Data synthesis of the scoping phase will use realist logic 
of analysis to align data from each eligible article with 
possible CMO configurations21 or specific elements that 
answer the research questions. These emerging findings 
and putative patterns of association within the data will 
be tested further in stage 2 to build causal explanations 
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Stage 2: Testing and refining the programme theories
Further iterative searches of the evidence will be directly 
informed by the CMOs developed in stage 1 as candidate 
programme theories. The iterative circle will continue 
throughout the course of the review until theoretical satu-
ration has been achieved.21 48
Data will be extracted using a bespoke data extraction 
form. It will include descriptive data on study charac-
teristics and is likely to focus on what can be learnt 
about the role and work of staff, resources required to 
implement an MDS, features of the settings (eg, work-
force capacity, size of care homes), explicit and implicit 
theories for how interventions were anticipated to work 
and patient and carer outcomes. A sample of the papers, 
including those that appear to offer most learning, and 
their completed data extraction forms will be shared 
across the project team to support ongoing discus-
sion and debate of the candidate theory(ies) and their 
supporting evidence.
Stage 3: Analysis and synthesis of evidence from the 
proposed programme theories
To support hypothesis refinement and ‘fine tune’ the theo-
ry(ies) that show the most promise, we will further test find-
ings from stage 2 in a series of interviews.49 We will do this 
through stakeholders’ consultation (box 1). It is acknowl-
edged in realist research that published literature alone 
cannot help to unearth the reasoning of end users of a 
programme.21 26 31 Therefore, the inclusion of primary data 
from stakeholders in the review will be an added value.
We will carry out up to eight individual semistructured 
interviews with frontline staff (staff from care homes who 
use predominately paper- based records and staff who 
routinely use electronic records for their residents) and 
care home managers and stakeholders who are experts 
regarding the use of care home residents’ data. The 
semistructured interviews will be guided by emerging 
programme theories from the early stages of the review.
Participants’ selection will be purposive based on their 
knowledge of using MDS in and with care homes. All 
participants will be sent a detailed participant information 
sheet via email and consent form prior to the interview. 
Interviews will be either face- to- face, online or telephone 
conversations. Interviews will be audio recorded and 
transcribed.21 Data will help to refine or refute the demi-
regularities seen in outcome patterns emerging from the 
empirical literature.26
At the end of the interviews, we will present and discuss 
the programme theories, with the supporting evidence 
for discussion, with the whole research project team.
A summary of the review process is presented in 
figure 1. The double arrows within or between stages indi-
cate iterative processes of the review.
The final programme theories will be synthesised narra-
tively, by logic models and/or summary tables where 
appropriate. The findings of the review will be written 
up according to the Realist And Meta- narrative Evidence 
Syntheses: Evolving Standards (RAMESES) guidance.48
Patient and public involvement
To keep the person being cared for at the centre of our 
thinking in ways that inform delivery of care or care home 
resident benefit, we will convene two care home- based resi-
dent patient and public involvement (PPI) groups that will 
meet throughout this review project. A member of this realist 
review, who is a former carer and IT specialist, will lead the 
PPI groups. We anticipate that input from residents and 
carers will help us to identify and understand the important 
contextual factors, the resource and reasoning that support 
the implementation of an MDS in long- term care settings. 
The PPI groups input will help us to tailor the stakeholders’ 
consultation, inform our theory (or theories) development 
and ensure that the final refined programme theory(ies) 
resonates with care home staff and residents’ experience.
DISCUSSION
This realist review will provide a theory- driven under-
standing of what needs to be in place for the successful 
implementation an MDS systems in care home settings 
Box 1 Stakeholders’ consultation
During stakeholders’ consultation interviews, we will explore:
1. The fit between the emerging programme theories and how stake-
holders understand what is needed for the development and use of 
minimum data set (MDS) in long- term care settings.
2. Alternative explanations stakeholders identify as relevant for the 
successful use of MDS by care home staff.
Figure 1 The realist review processes. CMO, context–
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to benefit residents, staff, families, service managers and 
commissioners.
Research has demonstrated the value of MDS to 
commissioners and service providers in the identifica-
tion of care needs.50–54 A research study that used care 
home- specific MDS identified particular implementa-
tion challenges.38 It enabled comprehensive analysis of 
baseline resident data and residents at risk but there was 
limited staff capacity to support and sustain its comple-
tion over time when it was not linked to other data collec-
tion responsibilities.38 This review addresses a gap in the 
evidence about what is needed to support uptake and 
implementation of an MDS, what needs to be in place 
for effective uptake and how an MDS is used in different 
circumstances to enable key care outcomes for residents. 
By identifying the causal mechanisms at work, the review 
findings will directly inform decision- making about how 
to design, tailor and implement an MDS that is accept-
able to staff and can inform residents’ everyday care.
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